IRIDEX Operating Margin from 2010 to 2024
| IRIX Stock | USD 1.80 0.03 1.69% |
Check IRIDEX financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IRIDEX's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 1.7 M or Total Revenue of 40.7 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 1.79. IRIDEX financial statements analysis is a perfect complement when working with IRIDEX Valuation or Volatility modules.
IRIDEX | Operating Margin |
Latest IRIDEX's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of IRIDEX over the last few years. It is IRIDEX's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IRIDEX's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.16) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
IRIDEX Operating Margin Regression Statistics
| Arithmetic Mean | (0.11) | |
| Coefficient Of Variation | (67.73) | |
| Mean Deviation | 0.05 | |
| Median | (0.14) | |
| Standard Deviation | 0.07 | |
| Sample Variance | 0.01 | |
| Range | 0.2182 | |
| R-Value | (0.61) | |
| Mean Square Error | 0 | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.07 |
IRIDEX Operating Margin History
About IRIDEX Financial Statements
IRIDEX investors use historical fundamental indicators, such as IRIDEX's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in IRIDEX. Please read more on our technical analysis and fundamental analysis pages.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Iridex Cp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 119 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.